EVENTIDE ASSET MANAGEMENT, LLC
Top Portfolio Positions
277 positions ·
$6,145,170,429 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| GH |
Guardant Health, Inc.
Healthcare
|
2,362,379 | $218,212,948 | 3.55% | |
| TT |
Trane Technologies plc
Industrials
|
406,555 | $169,427,730 | 2.76% | |
| LRCX |
Lam Research Corp
Technology
|
688,402 | $147,083,971 | 2.39% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
1,408,871 | $130,151,502 | 2.12% | |
| TRGP |
Targa Resources Corp.
Energy
|
502,287 | $125,938,419 | 2.05% | |
| XMTR |
Xometry, Inc.
Industrials
|
2,960,239 | $120,896,160 | 1.97% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
11,890,976 | $119,147,578 | 1.94% | |
| GEV |
GE Vernova Inc.
Industrials
|
133,200 | $116,270,280 | 1.89% | |
| ODFL |
Old Dominion Freight Line, Inc.
Industrials
|
591,691 | $115,616,421 | 1.88% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
2,197,385 | $108,023,446 | 1.76% |
Portfolio Trend
25 quarters · across all stocks
Holdings in PCVX
Shares Held
Position Value (USD)
11 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $79,860,108 | 1,374,292 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $42,315,686 | 917,115 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,663,466 | 379,330 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,573,063 | 848,141 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,755,884 | 470,230 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $31,389,544 | 383,454 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $43,817,288 | 383,454 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $55,813,443 | 739,153 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $44,893,741 | 657,206 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $38,132,536 | 607,206 | Shares | Sole | 2024-02-20 | |
| 2023-09-30 | $20,035,140 | 393,000 | Shares | Sole | 2023-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||